With the White House hosting a Precision Medicine Initiative Summit and National Institutes of Health Director Francis Collins announcing plans to enroll 79,000 volunteers this year in the PMI Cohort Program, there can be little doubt that precision medicine is gaining momentum on the national and global scene.
Health Decisions has been increasingly active in precision medicine as well. CEO Steve DeCherney, MD, MPH, participated this week in a meeting of the Personalized Medicine Coalition Science Policy Committee in Washington, DC. In addition, Health Decisions published a new precision medicine white paper to assist sponsors in addressing some key issues in securing a place in this exciting and rapidly evolving field. Nine Tips for Success in Precision Medicine: Concise Guidance for Biopharma and Diagnostic Developers is available for download immediately.